ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,922.39
1.64%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. PaxMedica Inc (PXMD)

  7. PaxMedica Inc (PXMD) ニュース

PXMD PaxMedica Inc

0.6883
0.00 (0.00%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
PaxMedica Inc PXMD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.6883 09:00:00
始値 安値 高値 終値 前日終値
0.6883 0.6883
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2621:30GLOBEPaxMedica's CEO and Malawi Health Official Discuss Urgent..
2024/4/2321:30GLOBEPaxMedica Responds to Emergency Request for IV Suramin and..
2024/4/1705:30GLOBEPaxMedica Receives Emergency Request for IV Suramin from..
2024/4/1205:30GLOBEPaxMedica Achieves Key Milestone in the Development of..
2024/3/1321:20GLOBEPaxMedica Updated Company Presentation Highlighting..
2024/3/1205:45EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2407:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1410:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0107:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3007:20EDGAR2Form 8-K - Current report
2024/1/1307:27EDGAR2Form 8-K - Current report
2023/12/2122:00EDGAR2Form 8-K - Current report
2023/12/0106:07EDGAR2Form 8-K - Current report
2023/11/3006:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/3006:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3006:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3006:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3006:05EDGAR2Form 8-K - Current report
2023/11/2306:24EDGAR2Form 8-K - Current report
2023/11/2306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2122:51EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/11/2114:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1722:00GLOBEPaxMedica Inc. Featured in Syndicated Broadcast Highlighting..
2023/11/1706:27EDGAR2Form S-1/A - General form for registration of securities..
2023/11/0922:00GLOBEPaxMedica's Chief Medical Officer Discusses FDA Meeting..
2023/11/0921:18EDGAR2Form 8-K - Current report
2023/11/0920:02EDGAR2Form S-1 - General form for registration of securities under..
2023/11/0221:30GLOBEPaxMedica Engages Bourne Partners to Explore Future..
2023/10/3121:00GLOBEPaxMedica Acquires Suramin Research Assets from Rediscovery..
2023/10/3105:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:05EDGAR2Form 8-K - Current report
2023/10/3100:30GLOBEPaxMedica Announces 1-for-17 Reverse Stock Split
2023/10/2702:51GLOBEPaxMedica's Research on Low Dose Suramin for Autism Spectrum..
2023/10/1823:10GLOBEThe Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz..
2023/9/2805:05EDGAR2Form 8-K - Current report
2023/9/1205:05EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/0705:25EDGAR2Form 8-K - Current report
2023/9/0205:33EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/3105:26EDGAR2Form 144 - Report of proposed sale of securities
2023/8/3105:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3021:00GLOBEPaxMedica to Present at the H.C. Wainwright 25th Annual..
2023/8/1805:05EDGAR2Form 8-K - Current report
2023/8/1622:00EDGAR2Form 8-K - Current report
2023/8/1621:30GLOBEPaxMedica Appoints David Hough M.D. as Chief Medical Officer

最近閲覧した銘柄

NASDAQ
PXMD
PaxMedica
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有